Innoviva (INVA) Enterprise Value (2009 - 2026)
Innoviva posted quarterly Enterprise Value of -$603.1 million for Q1 2026, down 89.0% year-on-year from -$5.5 billion in Q1 2025, and down 9.46% on a QoQ basis from -$550.9 million in Q4 2025.
Innoviva (INVA) has 18 years of Enterprise Value data on file, last reported at -$603.1 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 89.0% year-over-year to -$603.1 million; the trailing twelve-month figure through Mar 2026 stood at -$603.1 million (down 89.0% YoY), and the FY2025 full-year result was -$550.9 million, down 80.66% from the prior year.
- Enterprise Value for Q1 2026 stood at -$603.1 million, down from -$550.9 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$144.0 million in Q1 2023 and bottomed at -$603.1 million in Q1 2026.
- The 5-year median for Enterprise Value is -$283.6 million (2022), against an average of -$299.5 million.
- The widest annual swing landed in 2022, when Enterprise Value plunged 1469.95%; it then jumped 40.21% in 2023.
- A 5-year view of Enterprise Value shows it stood at -$291.0 million in 2022, then soared by 33.51% to -$193.5 million in 2023, then tumbled by 57.59% to -$305.0 million in 2024, then plunged by 80.66% to -$550.9 million in 2025, then decreased by 9.46% to -$603.1 million in 2026.
- The last three Enterprise Value figures came in at -$603.1 million (Q1 2026), -$550.9 million (Q4 2025), and -$476.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | -603.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -603.09 Mn |
| Dec 31, 2025 | -550.94 Mn |
| Sep 30, 2025 | -476.51 Mn |
| Jun 30, 2025 | -397.53 Mn |
| Mar 31, 2025 | -319.09 Mn |
| Dec 31, 2024 | -304.96 Mn |
| Sep 30, 2024 | -260.63 Mn |
| Jun 30, 2024 | -217.00 Mn |
| Mar 31, 2024 | -178.36 Mn |
| Dec 31, 2023 | -193.51 Mn |
| Sep 30, 2023 | -180.00 Mn |
| Jun 30, 2023 | -173.03 Mn |
| Mar 31, 2023 | -144.05 Mn |
| Dec 31, 2022 | -291.05 Mn |
| Sep 30, 2022 | -301.07 Mn |
| Jun 30, 2022 | -283.58 Mn |
| Mar 31, 2022 | -216.80 Mn |
| Dec 31, 2021 | -90.33 Mn |
| Sep 30, 2021 | -46.12 Mn |
| Jun 30, 2021 | 20.70 Mn |
| Mar 31, 2021 | -220.67 Mn |
| Dec 31, 2020 | -178.56 Mn |
| Sep 30, 2020 | -429.88 Mn |
| Jun 30, 2020 | -381.24 Mn |
| Mar 31, 2020 | -357.63 Mn |
| Dec 31, 2019 | -322.22 Mn |
| Sep 30, 2019 | -280.49 Mn |
| Jun 30, 2019 | -229.64 Mn |
| Mar 31, 2019 | -180.48 Mn |
| Dec 31, 2018 | -109.44 Mn |
| Sep 30, 2018 | -52.40 Mn |
| Jun 30, 2018 | -105.55 Mn |
| Mar 31, 2018 | -55.65 Mn |
| Dec 31, 2017 | -128.92 Mn |
| Sep 30, 2017 | -168.19 Mn |
| Jun 30, 2017 | -135.63 Mn |
| Mar 31, 2017 | -169.81 Mn |
| Dec 31, 2016 | -150.43 Mn |
| Sep 30, 2016 | -148.97 Mn |
| Jun 30, 2016 | -153.87 Mn |
| Mar 31, 2016 | -168.19 Mn |
| Dec 31, 2015 | -187.28 Mn |
| Sep 30, 2015 | -206.19 Mn |
| Jun 30, 2015 | -229.26 Mn |
| Mar 31, 2015 | -251.14 Mn |
| Dec 31, 2014 | -240.50 Mn |
| Sep 30, 2014 | -263.11 Mn |
| Jun 30, 2014 | -334.48 Mn |
| Mar 31, 2014 | -370.92 Mn |
| Dec 31, 2013 | -465.13 Mn |
| Sep 30, 2013 | -506.15 Mn |
| Jun 30, 2013 | -443.01 Mn |
| Mar 31, 2013 | -459.06 Mn |
| Dec 31, 2012 | -248.49 Mn |
| Sep 30, 2012 | -273.44 Mn |
| Jun 30, 2012 | -295.49 Mn |
| Mar 31, 2012 | -200.16 Mn |
| Dec 31, 2011 | -240.92 Mn |
| Sep 30, 2011 | -265.17 Mn |
| Jun 30, 2011 | -283.89 Mn |
| Mar 31, 2011 | -147.87 Mn |
| Dec 31, 2010 | -309.60 Mn |
| Sep 30, 2010 | -63.10 Mn |
| Jun 30, 2010 | -69.72 Mn |
| Dec 31, 2009 | -47.54 Mn |